Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

   
   

Disclosed is the surprising discovery that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are specific, accessible and stable markers of the luminal surface of tumor blood vessels. The present invention thus provides aminophospholipid-targeted diagnostic and therapeutic constructs for use in tumor intervention. Antibody-therapeutic agent conjugates and constructs that bind to aminophospholipids are particularly provided, as are methods of specifically delivering therapeutic agents, including toxins and coagulants, to the stably-expressed aminophospholipids of tumor blood vessels, thereby inducing thrombosis, necrosis and tumor regression.

É divulgado a descoberta surpreender que os aminophospholipids, tais como o phosphatidylserine e o phosphatidylethanolamine, são marcadores do específico, os acessíveis e os estáveis da superfície do luminal de embarcações de sangue do tumor. A invenção atual fornece assim construções diagnósticas e therapeutic aminophospholipid-alvejadas para o uso na intervenção do tumor. o agente Antibody-antibody-therapeutic conjugates e as construções que ligam aos aminophospholipids são fornecidas particularmente, como seja métodos especificamente de entregar agentes therapeutic, including toxins e coagulants, aos aminophospholipids estável-expressados de embarcações de sangue do tumor, induzindo desse modo o thrombosis, o necrosis e a regressão do tumor.

 
Web www.patentalert.com

< Omnidirectional antenna for wireless communication with implanted medical devices

< Use of nicotine or its derivatives in a drug for treating neurological disease, in particular Parkinson's disease

> Electrode lead with multiple branches

> Biodegradable drug delivery vascular stent

~ 00129